Podcasts

How innovation can broaden access and propel the CGT industry forward?

Invent Life Sciences #S3E2

In Part One of this two-part series, we reflected on the progress made in the Cell and Gene Therapy (CGT) industry and the importance of patient-centric development. In this episode, we dive into how we can continue to move forward, broaden access, and encourage the development of new treatments.

We’ll discuss the critical need to scale manufacturing, even in the early stages of development, to ensure that these therapies reach the patients who need them.

Guests:

  • Emma Chan, Director of Technical Development at Orchard Therapeutics
  • Matt Hewitt, Chief Technical Officer at the Manufacturing Business Division at Charles River Laboratories

Talk to us about your next project

Talk to us about your next project

Whether you would like to discuss a project or would like to learn more about our work, get in touch through the form below.

Last Updated
September 24, 2024

You might also like

Get the latest from TTP

Join our community to get the latest news and updates on our work at TTP.

You will occasionally receive expert insights from across our areas of focus and hear directly from our engineers and scientists on the newest developments in the field.

Get the latest from TTP

Join our community to get the latest news and updates on our work at TTP.

Want to work 
at TTP?

Find open positions and contact us to learn more.

Overlay title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

No items found.